New hip block could cut opioid use after surgery
NCT ID NCT04301687
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a targeted injection of numbing medicine around the hip joint can reduce pain and the need for opioid painkillers after hip replacement surgery. Half of the 95 participants will get the active nerve block, and half will get a placebo (salt water) injection. Neither the patients nor the doctors will know who got which treatment. The goal is to see if this simple procedure improves recovery and reduces opioid use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ropivacaine (local anesthetic)
What this could lead to
If it works, this could offer a better way to manage pain after hip replacement, reducing the need for strong painkillers like opioids.
What could go wrong
This is a small, early-stage trial. The nerve block may not provide significant pain relief compared to placebo, and there are risks like infection or nerve damage, though rare.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA, REGIONAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••